PL450034A1 - Zestaw biomarkerów oraz sposób diagnozowania in vitro nowotworu błony śluzowej trzonu macicy - Google Patents

Zestaw biomarkerów oraz sposób diagnozowania in vitro nowotworu błony śluzowej trzonu macicy

Info

Publication number
PL450034A1
PL450034A1 PL450034A PL45003424A PL450034A1 PL 450034 A1 PL450034 A1 PL 450034A1 PL 450034 A PL450034 A PL 450034A PL 45003424 A PL45003424 A PL 45003424A PL 450034 A1 PL450034 A1 PL 450034A1
Authority
PL
Poland
Prior art keywords
endometrial cancer
biomarkers
vitro diagnosis
subject
vitro
Prior art date
Application number
PL450034A
Other languages
English (en)
Inventor
Magdalena Górska-Ponikowska
Tomasz Kostrzewa
Sambor Sawicki
Katarzyna Bukato
Dagmara Jacewicz
Lucyna KONIECZNA
Tomasz BĄCZEK
Joanna Drzeżdżon
Original Assignee
Gdański Uniwersytet Medyczny
Uniwersytet Gdański
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gdański Uniwersytet Medyczny, Uniwersytet Gdański filed Critical Gdański Uniwersytet Medyczny
Priority to PL450034A priority Critical patent/PL450034A1/pl
Priority to EP25208945.3A priority patent/EP4729945A1/en
Publication of PL450034A1 publication Critical patent/PL450034A1/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Przedmiotem zgłoszenia jest zestaw biomarkerów zawierający estriadiol, 2-metoksyestriadol i nadtlenek wodoru do zastosowania w diagnozowaniu in vitro nowotworu błony śluzowej trzonu macicy u osobnika oraz sposób diagnozowania in vitro nowotworu błony śluzowej trzonu macicy u osobnika.
PL450034A 2024-10-15 2024-10-15 Zestaw biomarkerów oraz sposób diagnozowania in vitro nowotworu błony śluzowej trzonu macicy PL450034A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL450034A PL450034A1 (pl) 2024-10-15 2024-10-15 Zestaw biomarkerów oraz sposób diagnozowania in vitro nowotworu błony śluzowej trzonu macicy
EP25208945.3A EP4729945A1 (en) 2024-10-15 2025-10-15 Biomarker set and in vitro method for diagnosing endometrial cancer of the uterine corpus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL450034A PL450034A1 (pl) 2024-10-15 2024-10-15 Zestaw biomarkerów oraz sposób diagnozowania in vitro nowotworu błony śluzowej trzonu macicy

Publications (1)

Publication Number Publication Date
PL450034A1 true PL450034A1 (pl) 2026-04-20

Family

ID=99223052

Family Applications (1)

Application Number Title Priority Date Filing Date
PL450034A PL450034A1 (pl) 2024-10-15 2024-10-15 Zestaw biomarkerów oraz sposób diagnozowania in vitro nowotworu błony śluzowej trzonu macicy

Country Status (2)

Country Link
EP (1) EP4729945A1 (pl)
PL (1) PL450034A1 (pl)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL441360A1 (pl) * 2022-06-02 2023-12-04 Gdański Uniwersytet Medyczny Zastosowanie nadtlenku wodoru oraz 17β-estradiolu i jego metabolitów jako biomarkerów w sposobie diagnozowania in vitro chorób neurodegeneracyjnych

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649359B2 (en) * 2000-06-01 2003-11-18 The Brigham & Women's Hospital, Inc. Diagnosis of endometrial precancers
CN110596254A (zh) * 2018-06-13 2019-12-20 徐州医科大学 检测雌激素和/或其活性代谢产物的试剂盒及其应用

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL441360A1 (pl) * 2022-06-02 2023-12-04 Gdański Uniwersytet Medyczny Zastosowanie nadtlenku wodoru oraz 17β-estradiolu i jego metabolitów jako biomarkerów w sposobie diagnozowania in vitro chorób neurodegeneracyjnych

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AUDET-WALSH É. ET AL.: "J Clin Endocrinol Metab. 2011; 96(2): E330–E339", PROFILING OF ENDOGENOUS ESTROGENS, THEIR PRECURSORS, AND METABOLITES IN ENDOMETRIAL CANCER PATIENTS: ASSOCIATION WITH RISK AND RELATIONSHIP TO CLINICAL CHARACTERISTICS. *
BUKATO K. ET AL.: "Cell Commun Signal. 2024 April; 22, 205", ENDOGENOUS ESTROGEN METABOLITES AS OXIDATIVE STRESS MEDIATORS AND ENDOMETRIAL CANCER BIOMARKERS. *
ZHAO H. ET AL.: "Horm Metab Res. 2015; 47(2):158–164", ENDOGENOUS ESTROGEN METABOLITES AS BIOMARKERS FOR ENDOMETRIAL CANCER VIA A NOVEL METHOD OF LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY WITH HOLLOW FIBER LIQUID-PHASE MICROEXTRACTION. *

Also Published As

Publication number Publication date
EP4729945A1 (en) 2026-04-22

Similar Documents

Publication Publication Date Title
TWD226346S (zh) 平板電腦用擴充底座
PH12022553269A1 (en) Composition, kit and method for detecting sars-cov-2 and use thereof
ES2173424T3 (es) Metodos y aparatos para traduccion entre idiomas.
WO2021162981A3 (en) Methods and compositions for identifying castration resistant neuroendocrine prostate cancer
TWD232581S (zh) 半導體製造裝置用反應管的內管
Stokes et al. Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: a National Cancer Database analysis
PL450034A1 (pl) Zestaw biomarkerów oraz sposób diagnozowania in vitro nowotworu błony śluzowej trzonu macicy
WO2022212685A3 (en) Repetition of common search space sets of a downlink control channel
MX2023002899A (es) Sistema de deteccion y cuantificacion interferometrica y metodos de uso.
PL448391A1 (pl) Zintegrowane urządzenie do zanurzania w wielkoobszarowej rzeczywistości wirtualnej oraz sposób jego działania
PL443102A1 (pl) Nowa pochodna azetydyno-2,4-dionu, sposób otrzymywania nowej pochodnej azetydyno-2,4-dionu i zastosowanie nowej pochodnej azetydyno-2,4-dionu
WO2023017072A3 (en) Risk prediction model for prostate cancer
Lewis et al. Convergent Validity of the Depression–Happiness Scale with the Memorial University of Newfoundland Scale of Happiness
CL2023002360A1 (es) Camilla gineco obstétrica plegable portátil y procedimiento para operar dicha camilla
Chakiryan et al. The estimated prevalence of missed positive lymph nodes based on extent of lymphadenectomy at radical prostatectomy
MX2024010264A (es) Mediciones durante una transmisión de datos pequeños en redes de comunicación celular
JP1788978S (ja) ガス供給機器
JP1791653S (ja) ガス供給機器
JP1791654S (ja) ガス供給機器
Fritsche et al. Evaluation of the interest of women assisted by the Centro de Atenção à Mulher (CAM) of Rio do Sul in intimate aesthetic surgeries
PL131744U1 (pl) Ratunkowa Opaska Uciskowa
So Developing and Strengthening Nursing Leadership in Cancer Care and Control
Yunliang et al. Further Research on the Whole Blood Photo-Acoustic Spectrum of PIH (Pregnancy-induced Hypertension)
PL438655A1 (pl) Sposób określenia ryzyka raków u kobiet w zależności od stężenia ołowiu we krwi
TWD237370S (zh) 顯示螢幕之圖形化使用者介面（四）